Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits

by Robinson, James E., Hastie, Kathryn M., Cross, Robert W., Yenni, Rachael E., Elliott, Deborah H., Rouelle, Julie A., Kannadka, Chandrika B., Smira, Ashley A., Garry, Courtney E., Bradley, Benjamin T., Yu, Haini, Shaffer, Jeffrey G., Boisen, Matt L., Hartnett, Jessica N., Zandonatti, Michelle A., Rowland, Megan M., Heinrich, Megan L., Martínez-Sobrido, Luis, Cheng, Benson, de la Torre, Juan C., Andersen, Kristian G., Goba, Augustine, Momoh, Mambu, Fullah, Mohamed, Gbakie, Michael, Kanneh, Lansana, Koroma, Veronica J., Fonnie, Richard, Jalloh, Simbirie C., Kargbo, Brima, Vandi, Mohamed A., Gbetuwa, Momoh, Ikponmwosa, Odia, Asogun, Danny A., Okokhere, Peter O., Follarin, Onikepe A., Schieffelin, John S., Pitts, Kelly R., Geisbert, Joan B., Kulakoski, Peter C., Wilson, Russell B., Happi, Christian T., Sabeti, Pardis C., Gevao, Sahr M., Khan, S. Humarr, Grant, Donald S., Geisbert, Thomas W., Saphire, Erica Ollmann, Branco, Luis M., Garry, Robert F.
Published 2016